Metabolic Testing Market worth $475.75 Million by 2019


Posted June 21, 2016 by ryan_smith

According to estimates from the World Bank, the global healthcare spending increased from $3,770.14 billion in 2003 to $7,163.64 billion in 2012, at a CAGR of 7.39%. During this period

 
The report “Metabolic Testing Market by Product (CPET, Body Composition Analysis, ECG, Portable System), by Application (Critical Care, Lifestyle Diseases), by Technology (REE, Body Composition Analysis), by End User (Gym, Sports, Hospital) - Global Forecast to 2019”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global metabolic testing market along with the estimates and forecasts of the revenue and market share analysis.
Browse 68 market data tables and 88 figures spread through 150 pages and in-depth TOC on “Metabolic Testing Market by Product (CPET, Body Composition Analysis, ECG, Portable System), by Application (Critical Care, Lifestyle Diseases), by Technology (REE, Body Composition Analysis), by End User (Gym, Sports, Hospital) - Global Forecast to 2019"
http://www.marketsandmarkets.com/Market-Reports/metabolic-testing-equipment-market-149228862.html
Early buyers will receive 10% customization on reports.
According to estimates from the World Bank, the global healthcare spending increased from $3,770.14 billion in 2003 to $7,163.64 billion in 2012, at a CAGR of 7.39%. During this period, the public healthcare spending increased at a CAGR of 7.82%, from $2,182.47 billion in 2003 to $4,285.10 billion in 2012. On the other hand, the global population increased at a CAGR of 1.19%, from 6,302 million in 2003 to 7,008 million in 2012. The per capita healthcare spending also increased from $598 in 2003 to $1,022 in 2012, at a CAGR of 6.13%. Increase in healthcare expenditure is an important growth driver for the metabolic testing market.
The global metabolic testing market is expected to reach $475.75 million by 2019 from $332.78 million in 2014, growing at a CAGR of 7.41% from 2014 to 2019. Rising prevalence of lifestyle diseases is the primary growth driver for this market during the forecast period (2014–2019). Moreover, technological advancements and increasing healthcare expenditure are also expected to drive market growth. However, high cost of equipment and software and reimbursement may hinder the growth of this market.
The global metabolic testing market is segmented on the basis of products, technologies, and applications. CPET system was the largest product segment while VO2 max analysis was the largest technology segment in 2014. VO2 max assessment is an important parameter for metabolic testing and is one of the most widely prescribed metabolic tests for athletes, healthy individuals, as well as patients. The lifestyle diseases application segment accounted for the largest share of the global metabolic testing market owing to the rising prevalence of lifestyle diseases such as cardiovascular diseases, diabetes, and obesity.
The major players of this market are CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.).
Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Website Metabolic Testing Market worth $475.75 Million by 2019
Phone 1-888-600-6441
Business Address UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Country India
Categories Health , Medical
Tags market , metabolic , testing
Last Updated June 21, 2016